
Lars Aumann, PhD
Advertisement
Lars Aumann, PhD, is chief technology officer at ChromaCon AG
Articles by Lars Aumann, PhD



This article presents the multicolumn countercurrent solvent gradient purification (MCSGP) process, which uses three chromatographic columns, and incorporates the principle of countercurrent operation and the possibility of using solvent gradients. A MCSGP prototype has been built using commercial chromatographic equipment. The application of this prototype for purifying a MAb from a clarified cell culture supernatant using only a commercial, preparative cation exchange resin shows that the MCSGP process can result in purities and yields comparable to those of purification using Protein A.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Drug Digest: Reshoring Manufacturing and Securing Cold-Chain Supply for Biopharma
2
Samsung Biologics Secures 97.66% of PolyPeptide Shares in Tender Offer
3
Fresenius and WuXi Biologics Sign Exclusive Agreement Covering Up to 37 Biosimilar Candidates
4
Resolving the Speed-Specificity Trade-Off in Biopharma High-Throughput Screening
5



